Weill Cornell Medical College
Weill Cornell Medical College has been a leader in medical advances since its inception in 1898. Weill Cornell’s physicians and scientists contribute to a long-lasting reputation of excellence in academic medicine and medical research where they provide world-class clinical care, and strive to deliver the most innovative treatments and prevention strategies to their patients. Dr. Peter Martin, the Principal Investigator for the LEO consortium at Weill Cornell Medical College, is an Associate Professor of Medicine in the Division of Hematology/Oncology and Chief of the Lymphoma Program at Weill Cornell Medicine. He and his team are dedicated to investigating new clinical therapies to treat lymphoma.